These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5354286)

  • 21. [Various aspects of the significance of government control in drug supply].
    Teijgeler CA; Samsom RJ
    Pharm Weekbl; 1969 Jun; 104(26):539-49. PubMed ID: 5788999
    [No Abstract]   [Full Text] [Related]  

  • 22. Microbial content in non-sterile pharmaceuticals. I. Introduction.
    Dan Tidsskr Farm; 1968; 42(1):1-4. PubMed ID: 4968767
    [No Abstract]   [Full Text] [Related]  

  • 23. [The trade-mark].
    Kohlstaedt E
    Med Welt; 1969 Oct; 40():2209-11. PubMed ID: 5355668
    [No Abstract]   [Full Text] [Related]  

  • 24. Problems of prescribing in Ireland. II. Medical, pharmaceutical and legal implications.
    Cannon PJ
    J Ir Med Assoc; 1971 Jun; 64(414):313-8. PubMed ID: 4933212
    [No Abstract]   [Full Text] [Related]  

  • 25. ASHP technical assistance bulletin on compounding nonsterile products in pharmacies. American Society of Hospital Pharmacists.
    Am J Hosp Pharm; 1994 Jun; 51(11):1441-8. PubMed ID: 7942879
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pharmaceutical preparations in pressure packaging. I].
    Knap J; Hornícek B
    Cesk Farm; 1968 Jan; 17(1):46-50. PubMed ID: 4875755
    [No Abstract]   [Full Text] [Related]  

  • 27. Formulation of a parenteral antimalarial solution--a French undergraduate project in industrial pharmacy.
    Jeannin C; Pourcelot Y
    Am J Pharm Educ; 1977 Feb; 41(1):59-61. PubMed ID: 10236632
    [No Abstract]   [Full Text] [Related]  

  • 28. [Filtration of injection solutions in industrial preparations].
    Hartvich J
    Cesk Farm; 1970 May; 19(4):147-53. PubMed ID: 4913072
    [No Abstract]   [Full Text] [Related]  

  • 29. Nanosuspensions in drug delivery.
    Rabinow BE
    Nat Rev Drug Discov; 2004 Sep; 3(9):785-96. PubMed ID: 15340388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new formulation concept for drugs with poor water solubility for parenteral application.
    Jürgens K; Müller BW
    Pharmazie; 2005 Sep; 60(9):665-70. PubMed ID: 16222865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The origin of particulate contamination in injectable solutions].
    Lambert G; Moës A
    J Pharm Belg; 1972; 27(4):402-16. PubMed ID: 4681074
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of laminar air flow and nursing station environments for the preparation of intravenous admixtures.
    Morgan E; Fincher JH; Sadik F; Mikeal RL
    Am J Hosp Pharm; 1972 Dec; 29(12):1020-4. PubMed ID: 4646699
    [No Abstract]   [Full Text] [Related]  

  • 33. [Preparation and filling of eyedrops].
    Wolff D
    Pharm Prax; 1970; 3():58-9. PubMed ID: 5430539
    [No Abstract]   [Full Text] [Related]  

  • 34. [Extraction behavior of polypropylenes. 87. Problems in the use of plastic containers for fluid drugs].
    Schleuder M; Müller PG; Pomper E; Göckeritz D
    Pharmazie; 1984 Aug; 39(8):553-6. PubMed ID: 6504979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Physicochemical incompatibilities of injectable drugs].
    Hoffman M; Hazebroucq G
    Sem Hop; 1983 Feb; 59(8):541-7. PubMed ID: 6302899
    [No Abstract]   [Full Text] [Related]  

  • 36. Dosage form design and development.
    Allen LV
    Clin Ther; 2008 Nov; 30(11):2102-11. PubMed ID: 19108798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Particles in injectable solutes. 3. Influence of perfusion of massive solutes containing particles of known concentration and diameter, in rabbits].
    Araud D; Moreau R; Vignon H
    J Med Lyon; 1972 Feb; 53(223):239-44. PubMed ID: 4339051
    [No Abstract]   [Full Text] [Related]  

  • 38. Formulation for optimal safety and effectiveness.
    Schlichting DA
    Am J Pharm Sci Support Public Health; 1970; 142(1):16-22. PubMed ID: 5535904
    [No Abstract]   [Full Text] [Related]  

  • 39. [A department for the production of sterile injectable solutions].
    Ahrens G
    Pharm Prax; 1966; 5():115-8. PubMed ID: 5986224
    [No Abstract]   [Full Text] [Related]  

  • 40. [How a medication is developed].
    Klewes J
    Quintessenz J; 1987 Mar; 17(3):283-6. PubMed ID: 3473565
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.